Gender differences in the response of CD-1 mouse bone to parathyroid hormone: Potential role of IGF-I

Journal of Endocrinology

Volumn 189, Issue 2, 2006, Pages 279-287

  Wang, Yongmei ^a   Sakata, Takeshi ^a   Elalieh, Hashem Z ^a   Munson, Scott J ^a   Burghardt, Andrew ^b   Majumdar, Sharmila ^b   Halloran, Bernard P ^a   Bikle, Daniel D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PARATHYROID HORMONE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW CELL; BONE MASS; BONE MINERAL; CELL CULTURE; CONTROLLED STUDY; CORTICAL BONE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OSSIFICATION; PERIOSTEUM; PRIORITY JOURNAL; SEX DIFFERENCE; STROMA CELL;

ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE MARROW CELLS; CARRIER PROTEINS; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; INSULIN-LIKE GROWTH FACTOR I; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; ORGAN SIZE; OSTEOGENESIS; PARATHYROID HORMONE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR, IGF TYPE 1; SEX FACTORS; STROMAL CELLS; TIBIA;

EID: 33646757529     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06351     Document Type: Article

References (35)

1. Alexander JM, Bab I, Fish S, Muller R, Uchiyama T, Gronowicz G, Nahounou M, Zhao Q, White DW, Chorev M et al. 2001 Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice. Journal of Bone and Mineral Research 16 1665-1673.
2. Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C & Halloran B 2001 The skeletal structure of insulin-like growth factor I-deficient mice. Journal of Bone and Mineral Research 16 2320-2329.
3. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S & Halloran BP 2002 Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. Journal of Bone and Mineral Research 17 1570-1578.
4. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J et al. 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. Journal of Bone and Mineral Research 16 1846-1853.
5. Eisman JA 1999 Genetics of osteoporosis. Endocrine Reviews 20 788-804.
6. Frolik CA, Cain RL, Sato M, Harvey AK, Chandrasekhar S, Black EC, Tashjian AH Jr. & Hock JM 1999 Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats. Journal of Bone and Mineral Research 14 163-172
7. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, Gray JW & Jensen RH 2000 Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Research 60 5405-5409.
8. Halloran BP, Bikle DD, Harris J, Tanner S, Curren T & Morey-Holton E 1997 Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading. Journal of Bone and Mineral Research 12 1068-1074.
9. Heid C A, Stevens J, Livak KJ & Williams PM 1996 Real time quantitative PCR. Genome Research 6 986-994.
10. Hock JM 2000 Discrimination among osteoblasts? Parathyroid hormone analog may reveal site-specific differences in mice. Bone 27 467-469.
11. Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J & Lindsay R 2002 Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. Journal of Bone and Mineral Research 17 808-816.
12. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S & Yamaguchi A 1997 Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. Journal of Clinical Investigation 99 2961-2970.
13. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM & Manolagas SC 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. Journal of Clinical Investigation 104 439-446.
14. Johansson AG, Engstrom BE, Ljunghall S, Karlsson FA & Burman P 1999 Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 84 2002-2007.
15. Kim BT, Mosekilde L, Duan Y, Zhang XZ, Tornvig L, Thomsen JS & Seeman E 2003 The structural and hormonal basis of sex differences in peak appendicular bone strength in rats. Journal of Bone and Mineral Research 18 150-155.
16. Kostenuik PJ, Harris J, Halloran BP, Turner RT, Morey-Holton ER & Bikle DD 1999 Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I. Journal of Bone and Mineral Research 14 21-31.
17. Lee SK & Lorenzo JA 1999 Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140 3552-3561.
18. Locklin RM, Khosla S, Turner RT & Riggs BL 2003 Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. Journal of Cellular Biochemistry 89 180-190.
19. Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ & Onyia JE 2001 Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142 4047-4054.
20. McCarthy TL & Centrella M 2001 Local IGF-I expression and bone formation. Growth Hormone and IGF Research 11 213-219.
21. McCarthy T L, Ji C, Shu H, Casinghino, S, Crothers K, Rotwein P & Centrella M 1997 17 beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures. Journal of Biological Chemistry 272 18132-18139.
22. Naganathan V, Macgregor A, Snieder H, Nguyen T, Spector T & Sambrook P 2002 Gender differences in the genetic factors responsible for variation in bone density and ultrasound. Journal of Bone and Mineral Research 17 725-733.
23. Nasu M, Sugimoto T, Kaji H & Chihara K 2000 Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cells: role of insulin-like growth factor (IGF)-I and IGF-binding protein-5. Journal of Endocrinology 167 305-313.
24. Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, Suda T, Yoshiki S & Takahashi HE 1994 Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15 717-723.
25. Orwoll ES, Belknap JK & Klein RF 2001 Gender specificity in the genetic determinants of peak bone mass. Journal of Bone and Mineral Research 16 1962-1971.
26. Parfitt AM 2002 Parathyroid hormone and periosteal bone expansion. Journal of Bone and Mineral Research 17 1741-1743.
27. Rubin MR, Cosman F, Lindsay R & Bilezikian JP 2002 The anabolic effects of parathyroid hormone. Osteoporosis International 13 267-277.
28. Sabatini M, Lesur C, Pacherie M, Pastoureau P, Kucharczyk N, Fauchere JL & Bonnet J 1996 Effects of parathyroid hormone and agonists of the adenylyl cyclase and protein kinase C pathways on bone cell proliferation. Bone 18 59-65.
29. Schiller PC, D'Ippolito G, Roos BA & Howard GA 1999 Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. Journal of Bone and Mineral Research 14 1504-1512.
30. Somjen D, Mor Z & Kaye AM 1994 Age dependence and modulation by gonadectomy of the sex-specific response of rat diaphyseal bone to gonadal steroids. Endocrinology 134 809-814.
31. Span JP, Pieters GF, Sweep CG, Hermus AR & Smals AG 2000 Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. Journal of Clinical Endocrinology and Metabolism 85 1121-1125.
32. Turner RT 1999 Mice, estrogen, and postmenopausal osteoporosis. Journal of Bone and Mineral Research 14 187-191.
33. von Stechow D, Zurakowski D, Pettit AR, Muller R, Gronowicz G, Chorev M, Otu H, Libermann T & Alexander JM 2004 Differential transcriptional effects of PTH and estrogen during anabolic bone formation. Journal of Cellular Biochemistry 93 476-490.
34. Watson P, Lazowski D, Han V, Fraher L, Steer B & Hodsman A 1995 Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16 357-365.
35. Zhang XZ, Kalu DN, Erbas B, Hopper JL & Seeman E 1999 The effects of gonadectomy on bone size, mass, and volumetric density in growing rats are gender-, site-, and growth hormone-specific. Journal of Bone and Mineral Research 14 802-809.